Preclinical Investigation of Combined Targeting the Immune Signaling Axis Btk/Pd-L1/Pd-L2 for Combating Drug Resistant Glioblastoma Multiforme (1/3)

林, 乾閔 (PI)

Division of Neurosurgery

Project: A - Government Institution › b - National Science and Technology Council

Description

本篇研究將探究Btk/PD-L1/PD-L2訊號軸對GBM進展、腫瘤免疫和耐藥性的影響，並且可能在未來發展成為新的診斷方針與治療策略。

Status	Finished
Effective start/end date	8/1/22 → 7/31/23

Keywords

glioblastoma
glioma stem cells (GSCs)
Btk/PD-L1/PD-L2 signal axis
Remibrutinib
exosomes
hsa-miR-4434
precision tumor immunotherapy

Access Project

https://www.grb.gov.tw/search/planDetail?id=14513704